Seuraa
Brooke E. Nichols
Brooke E. Nichols
Associate Professor, Department of Global Health, Boston University School of Public Health
Vahvistettu sähköpostiosoite verkkotunnuksessa bu.edu - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Population density and basic reproductive number of COVID-19 across United States counties
KTL Sy, LF White, BE Nichols
PloS one 16 (4), e0249271, 2021
2552021
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2382014
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
1782015
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ...
The Lancet Infectious Diseases 16 (12), 1423-1429, 2016
1362016
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
K van der Straten, D Guerra, MJ van Gils, I Bontjer, TG Caniels, ...
Immunity 55 (9), 1725-1731. e4, 2022
132*2022
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review
L Long, S Kuchukhidze, S Pascoe, BE Nichols, MP Fox, R Cele, ...
Journal of the International AIDS Society 23 (11), e25640, 2020
1312020
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
DAMC Van De Vijver, BE Nichols, UL Abbas, CAB Boucher, V Cambiano, ...
Aids 27 (18), 2943-2951, 2013
1002013
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
1002012
Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial
K Dovel, F Shaba, OA Offorjebe, K Balakasi, M Nyirenda, K Phiri, ...
The Lancet Global Health 8 (2), e276-e287, 2020
96*2020
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
AN Phillips, V Cambiano, F Nakagawa, P Revill, MR Jordan, TB Hallett, ...
The lancet HIV 5 (3), e146-e154, 2018
832018
Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, ...
Open Forum Infectious Diseases 8 (3), ofab040, 2021
582021
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study
BE Nichols, CAB Boucher, JH van Dijk, PE Thuma, JL Nouwen, ...
PLoS One 8 (3), e59549, 2013
562013
Differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: a landscape analysis
A Huber, S Pascoe, B Nichols, L Long, S Kuchukhidze, B Phiri, T Tchereni, ...
Global Health: Science and Practice 9 (2), 296-307, 2021
492021
Community-based delivery of HIV treatment in Zambia: costs and outcomes
BE Nichols, R Cele, L Jamieson, LC Long, Z Siwale, P Banda, C Moyo, ...
Aids 35 (2), 299-306, 2021
472021
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
DAMC van de Vijver, AK Richter, CAB Boucher, ...
Eurosurveillance 24 (7), 1800398, 2019
472019
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men
S Popping, SJ Hullegie, A Boerekamps, BJA Rijnders, RJ de Knegt, ...
PLoS One 14 (1), e0210179, 2019
47*2019
Quality of life among people living with HIV in England and the Netherlands: a population-based study
S Popping, M Kall, BE Nichols, E Stempher, L Versteegh, ...
The Lancet Regional Health–Europe 8, 2021
412021
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled …
L Jamieson, LF Johnson, BE Nichols, S Delany-Moretlwe, ...
The Lancet HIV 9 (12), e857-e867, 2022
40*2022
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins, S Briand, M Van Kerkhove, ...
Nature Genetics 55 (1), 26-33, 2023
39*2023
Increasing the use of second‐line therapy is a cost‐effective approach to prevent the spread of drug‐resistant HIV: a mathematical modelling study
BE Nichols, KCE Sigaloff, C Kityo, RL Hamers, R Baltussen, S Bertagnolio, ...
Journal of the International AIDS Society 17 (1), 19164, 2014
392014
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20